Quantbot Technologies LP Allovir, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.64 - $0.78 $3,344 - $4,075	-5,225 Reduced 61.59%	3,259 $2,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $2.39 $5,769 - $20,276	8,484 New	8,484 $5,000
Q3 2022 Nov 07, 2022	BUY	$4.13 - $8.79 $13,112 - $27,908	3,175 New	3,175 $25,000
Q2 2022 Aug 09, 2022	SELL	$3.26 - $7.06 $7,651 - $16,569	-2,347 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.75 - $13.52 $1,350 - $2,704	-200 Reduced 7.85%	2,347 $15,000
Q4 2021 Feb 11, 2022	SELL	$12.94 - $25.99 $32,350 - $64,974	-2,500 Reduced 49.53%	2,547 $32,000
Q3 2021 Nov 09, 2021	BUY	$16.97 - $25.06 $85,647 - $126,477	5,047 New	5,047 $126,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.